Surgery of the Adrenals

  • Anthony J. Edis
  • Luis A. Ayala
  • Richard H. Egdahl
Chapter
Part of the Comprehensive Manuals of Surgical Specialties book series (CMSS)

Abstract

Hyperplasia or neoplasia of the adrenal cortex produces aldosterone excess (aldosteronism), hypercortisolism (Cushing’s syndrome), virilism (adreno-genital syndrome), or a mixture of these, according to whether the cells that produce mineralocorticoids, glucocorticoids, or sex hormones, respectively, are in relative excess.

Keywords

Primary Aldosteronism Adrenal Tumor Adrenal Vein Bilateral Adrenalectomy Adrenocortical Tumor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Baer L, Sommers SC, Krakoff L: Pseudoprimary aldosteronism. An entity distinct from true primary aldosteronism. Circ Res Suppl 1 26–27: 203, 1970.Google Scholar
  2. 2.
    Bennett AH, Harrison JH, Thorn GW: Neoplasms of the adrenal gland. J Urol 106: 607, 1971.PubMedGoogle Scholar
  3. 3.
    Besser GM, Edwards CRW: Cushing’s syndrome. Clin Endocrinol Metab 1: 451, 1972.CrossRefGoogle Scholar
  4. 4.
    Bhanalaph T, Varkarakis MJ, Murphy GP: Current status of bilateral adrenalectomy for advanced prostatic carcinoma. Ann Surg 179: 17, 1974.PubMedCrossRefGoogle Scholar
  5. 5.
    Biglieri EG, Slaton PE, Jr, Silen WJ, et al: Postoperative studies of adrenal function in primary aldosteronism. J Clin Endocrinol Metab 26: 553, 1966.PubMedCrossRefGoogle Scholar
  6. 6.
    Bongiovanni AM, Root AW: The adrenogenital syndrome. N Engl J Med 268: 1283, 1963.PubMedCrossRefGoogle Scholar
  7. 7.
    Brown PW, Terz JJ, King R, et al: Bilateral adrenalectomy for metastatic breast carcinoma. Arch Surg 110:77, 1975.Google Scholar
  8. 8.
    Case records of the Massachusetts General Hospital. N Engl J Med 287: 656, 1972.CrossRefGoogle Scholar
  9. 9.
    Case records of the Massachusetts General Hospital. N Engl J Med 289: 472, 1973.CrossRefGoogle Scholar
  10. 10.
    Conn JW, Knopf RF, Nesbit RM: Clinical characteristics of primary aldosteronism from analysis of 145 cases. Am J Surg 107: 159, 1964.PubMedCrossRefGoogle Scholar
  11. 11.
    Conn JW, Morita R, Cohen EL, et al: Primary aldosteronism. Photoscanning of tumors after administration of 131I-19-iodocholesterol. Arch Intern Med 129: 417, 1972.PubMedCrossRefGoogle Scholar
  12. 12.
    Conn JW, Rovner DR, Cohen EC, et al: Preoperative diagnosis of primary aldosteronism. Arch Intern Med 123: 113, 1969.PubMedCrossRefGoogle Scholar
  13. 13.
    Conn JW, Rovner DR, Cohen EC, et al: Normokalemic primary aldosteronism: Its masquerade as `essential’ hypertension. JAMA 195: 21, 1966.CrossRefGoogle Scholar
  14. 14.
    Crout JR, Sjoerdsma A: Turnover and metabolism of catecholamines in patients with pheochromocytoma. J Clin Invest 43: 94, 1964.PubMedCrossRefGoogle Scholar
  15. 15.
    Dao TL: Ablation therapy for hormone-dependent tumors. Ann Rev Med 23: 1, 1972.PubMedCrossRefGoogle Scholar
  16. 16.
    Egdahl RH: Surgery of the adrenal gland. N Engl J Med 278: 939, 1968.CrossRefGoogle Scholar
  17. 17.
    Egdahl RH, Chobanian AV: Acute pheochromocytoma. Surg Clin North Am 46: 645, 1966.PubMedGoogle Scholar
  18. 18.
    Egdahl RH, Melby JC: Recurrent Cushing’s disease and intermittent functional adrenal cortical insufficiency following subtotal adrenalectomy. Ann Surg 166: 586, 1967.PubMedCrossRefGoogle Scholar
  19. 19.
    Engelman K, Hammond WG: Adrenalin production by an intrathoracic pheochromocytoma. Lancet 1: 609, 1968.PubMedCrossRefGoogle Scholar
  20. 20.
    Engelman K, Sjoerdsma A: Chronic medical therapy for pheochromocytoma. Ann Intern Med 61: 229, 1964.PubMedGoogle Scholar
  21. 21.
    Ferris JB, Brown JJ, Fraser R, et al: Hypertension with aldosterone excess and low plasma renin: Preoperative distinction between patients with and without adrenocortical tumor. Lancet 2: 995, 1970.CrossRefGoogle Scholar
  22. 22.
    Fracchia AA, Farrow JH, Miller TR, et al: Hypophysectomy as compared with adrenalectomy in the treatment of advanced carcinoma of the breast. Surg Gynecol Obstet 133: 241, 1971.PubMedGoogle Scholar
  23. 23.
    Fracchia AA, Randall HT, Farrow JH: The results of adrenalectomy in advanced breast cancer in 500 consecutive patients. Surg Gynecol Obstet 125: 747, 1967.PubMedGoogle Scholar
  24. 24.
    Freeark RJ, Waldstein SS: Present status of the diagnosis and treatment of Cushing’s syndrome. Surg Clin North Am 49: 179, 1969.Google Scholar
  25. 25.
    Fries JG, Chamberlain JA: Extra-adrenal pheochromocytoma: Literature review and report of a cervical pheochromocytoma. Surgery 63: 268, 1968.Google Scholar
  26. 26.
    Gabrilove JL, Sharma DC, Wotiz HH, et al: Feminizing adrenocortical tumors in the male: Review of 52 cases including a case report. Medicine 44: 37, 1965.PubMedCrossRefGoogle Scholar
  27. 27 Ganguly A, Melada GA, Luetscher JA, et al: Control of plasma aldosterone in primary aldosteronism: distinction between adenoma and hyperplasia. J Clin Google Scholar
  28. Endocrinol Metab 37:765, 1973.Google Scholar
  29. 28.
    George GM, Wright L, Bell NH, et al: The syndrome of primary aldosteronism. Am J Med 48: 343, 1970.PubMedCrossRefGoogle Scholar
  30. 29.
    Gifford RW, Kuale WF, Maher FT, et al: Clinical features, diagnosis and treatment of pheochromocytoma: A review of 76 cases. Mayo Clin Proc 39: 281, 1964.PubMedGoogle Scholar
  31. 30.
    Gitlow SE, Mendlowitz M, Bertani LM: The biochemical techniques for detecting and establishing the presence of a pheochromocytoma. Am J Cardiol 26: 270, 1970.PubMedCrossRefGoogle Scholar
  32. 31.
    Gitlow SE, Pertsemlidis D, Bertani LM: Management of patients with pheochromocytoma. Am Heart J 82: 557, 1974.CrossRefGoogle Scholar
  33. 32.
    Glashien AJ, Mansuy MM, Littman DS: Pheochromocytoma: The relationship to the neurocutaneous syndromes. Am J Med 14: 318, 1953.CrossRefGoogle Scholar
  34. 33.
    Graham JB: Collective review: Pheochromocytoma and hypertension: An analysis of 207 cases. Int Abst Surg 92: 105, 1951.Google Scholar
  35. 34.
    Harrison TS, Seaton JF, Cerny JC, et al: Localization of pheochromocytoma by caval catheterization. Arch Surg 155: 339, 1967.CrossRefGoogle Scholar
  36. 35.
    Heinbecker P, O’Neal LW, Ackerman LV: Functioning and nonfunctioning adrenal cortical tumors. Surg Gynecol Obstet 105: 21, 1957.PubMedGoogle Scholar
  37. 36.
    Hobbs JR, Salih H, Flax H, et al: Prolactin dependence in human breast cancer. Proc R Soc Med 66: 866, 1973.PubMedGoogle Scholar
  38. 37.
    Hoffman DL, Mattox VR: Treatment of adrenocortical carcinoma with o,p’-DDD. Med Clin North Am 56: 999, 1972.PubMedGoogle Scholar
  39. 38.
    Hoge AF, Hartsuck JM, Kollmorgan GM, et al: Endocrine and immunologic studies in breast cancer. Am J Surg 126: 722, 1973.PubMedCrossRefGoogle Scholar
  40. 39.
    Horsley JS III, Alrich EM, Sears HF, et al: Adrenalectomy for metastatic mammary cancer. Ann Surg 173: 906, 1971.PubMedCrossRefGoogle Scholar
  41. 40.
    Huggins CB, Scott WW: Bilateral adrenalectomy in prostatic cancer. Ann Surg 122: 1031, 1945.CrossRefGoogle Scholar
  42. 41.
    Huggins CB, Bergenstal DM: Inhibition of human mammary and prostatic cancer by adrenalectomy. Cancer Res 12: 134, 1952.PubMedGoogle Scholar
  43. 42.
    Hume DM: Pheochromocytoma in the adult and in the child. Am J Surg 99: 458, 1960.PubMedCrossRefGoogle Scholar
  44. 43.
    Hutter AM, Jr, Kayhoe DE: Adrenal cortical carcinoma. Results of treatment with o,p’-DDD in 138 patients. Am J Med 41: 581, 1966.PubMedCrossRefGoogle Scholar
  45. 44.
    Hutter AM, Jr, Kayhoe DE: Adrenal cortical carcinoma. Am J Med 41: 572, 1966.PubMedCrossRefGoogle Scholar
  46. 45.
    Jensen EV: Editorial. Some newer endocrine aspects of breast cancer. N Engl J Med 291: 1252, 1974.PubMedCrossRefGoogle Scholar
  47. 46.
    Kahn PC: The radiologic identification of functioning adrenal tumors. Radiol Clin North Am 5: 221, 1967.PubMedGoogle Scholar
  48. 47.
    Kahn PC, Kelleher ND, Egdahl RH, et al: Adrenal arteriography and venography in primary aldosteronism. Radiology 101: 71, 1971.PubMedGoogle Scholar
  49. 48.
    Kaufman S, Goldstein M: Combination chemotherapy in disseminated carcinoma of the breast. Surg Gynecol Obstet: 137: 83, 1973.PubMedGoogle Scholar
  50. 49.
    Lawler DP: Preoperative prognosis of primary aldosteronism. Am J Med 41: 855, 1966.CrossRefGoogle Scholar
  51. 50.
    Lee JM, Abeloff MD, Lenhard RE, Jr, et al: An evaluation of five-drug combination chemotherapy in the management of recurrent carcinoma of the breast. Surg Gynecol Obstet 138: 77, 1974.PubMedGoogle Scholar
  52. 51.
    Liddle GW, Melmon KL: The adrenals, in Textbook of Endocrinology, Fifth Edition ( RH Williams, editor). WB Saunders Company, Philadelphia, 1974.Google Scholar
  53. 52.
    Lipsett MB, Hertz R, Ross GT: Clinical and pathophysiologic aspects of adrenocortical carcinoma. Am J Med 35: 374, 1963.PubMedCrossRefGoogle Scholar
  54. 53.
    Mac Donald I: Endocrine ablation in disseminated mammary carcinoma. Surg Gynecol Obstet 115: 215, 1962.Google Scholar
  55. 54.
    Mahoney EM, Crocker DW, Friend DG, et al: Adrenal and extraadrenal pheo-chromocytomas: Localization by vena cavai sampling and observations on renal juxtaglomerular apparatus. J Urol 108: 4, 1972.PubMedGoogle Scholar
  56. 55.
    Mannix H, Jr, O’Grady WP, Gitlow SI: Extraadrenal pheochromocytoma producing epinephrine. Arch Surg 104: 216, 1972.PubMedCrossRefGoogle Scholar
  57. 56.
    Melby JC: Editorial. Therapeutic possibilities in Cushing’s syndrome. N Engl J Med 285: 288, 1971.PubMedCrossRefGoogle Scholar
  58. 57.
    Melby JC: Primary aldosteronism. Practitioner 200: 519, 1968.PubMedGoogle Scholar
  59. 58.
    Melby JC: Identifying the adrenal lesion in primary aldosteronism. Ann Intern Med 76: 1039, 1972.PubMedGoogle Scholar
  60. 59.
    Melby JC: Assessment of adrenocortical function. N Engl J Med 285: 735, 1971.PubMedCrossRefGoogle Scholar
  61. 60.
    Melby JC, Spark RF, Dale SL, et al: Diagnosis and localization of aldosteroneproducing adenomas by adrenal vein catheterization. N Engl J Med 277: 1050, 1967.PubMedCrossRefGoogle Scholar
  62. 61.
    Minton JP, Dickey RP: Levodopa test to predict response of carcinoma of the breast to surgical ablation of endocrine glands. Surg Gynecol Obstet 136: 971, 1973.PubMedGoogle Scholar
  63. 62.
    Mitty HA, Nicolis GL, Gabrilove JL: Adrenal venography: Clinical-roentgenographic correlation in 80 patients. Am J Roentgenol Radium Ther Nucl Med 119: 564, 1973.PubMedGoogle Scholar
  64. 63.
    Moore FD, Van Devanter SB, Boyden CM, et al: Adrenalectomy with chemotherapy in the treatment of advanced breast cancer: Objective and subjective response rates, duration and quality of life. Surgery 76: 376, 1974.PubMedGoogle Scholar
  65. 64.
    Moses DC, Schteingart DE, Sherman MF, et al: Efficacy of radiocholesterol imaging of the adrenal glands in Cushing’s syndrome. Surg Gynecol Obstet 139: 201, 1974.PubMedGoogle Scholar
  66. 65.
    Nelson DH, Sprunt JG: Pituitary tumors postadrenalectomy for Cushing’s syndrome, International Congress, Series 83, Proceedings of the Second International Congress on Endocrinology, London, 1964. Excerpta Medica, Amsterdam, 1965, p. 1053.Google Scholar
  67. 66.
    Nemoto T, Dao TL: Significance of liver metastasis in women with disseminated breast cancer undergoing endocrine ablative surgery. Cancer 19: 421, 1966.PubMedCrossRefGoogle Scholar
  68. 67.
    Nourok DS, Gwinup G, Hamwi GJ: Phentolamine resistant pheochromocytoma treated with sodium nitroprusside. JAMA 183:841, 1963.Google Scholar
  69. 68.
    Orth DN, Liddle GW: Results of treatment in 108 patients with Cushing’s syndrome. N Engl J Med 285: 243, 1971.PubMedCrossRefGoogle Scholar
  70. 69.
    Pearse AGE: The cytochemistry and ultrastructure of polypeptide hormone-producing cells of the APUD series and their embryologic, physiologic, and pathologic implications of the concept. J Histochem Cytochem 17: 303, 1969.PubMedCrossRefGoogle Scholar
  71. 70.
    Perry L, Gould A: The anesthetic management of pheochromocytoma. Effect of preoperative adrenergic blocking drugs. Anesth Analg 51: 36, 1972.PubMedCrossRefGoogle Scholar
  72. 71.
    Rees LH, Ratcliffe JG: Ectopic hormone production by nonendocrine tumors. Clin Endocrino13:263, 1974.Google Scholar
  73. 72.
    ReMine WH, Chong GC, van Heerden JA, et al: Current management of pheochromocytoma. Ann Surg 179: 740, 1974.PubMedCrossRefGoogle Scholar
  74. 73.
    Riley PA, Lattes T, Sutton PM: Hormone assays on breast tumor cultures. Lancet ii: 818, 1973.Google Scholar
  75. 74.
    Rosati LA, Augua NA: Ischemic enterocolitis in pheochromocytoma. Gastroenterology 60: 581, 1971.PubMedGoogle Scholar
  76. 75.
    Rossi P, Young IS, Panke WF: Techniques, usefulness, and hazards of arteriography of pheochromocytoma. JAMA 205: 547, 1968.PubMedCrossRefGoogle Scholar
  77. 76.
    Scharf Y, Nahir M, Plavnic Y, et al: Intermittent claudication with pheochromocytoma. JAMA 215: 1323, 1971.PubMedCrossRefGoogle Scholar
  78. 77.
    Schmidt ML, Nemoto T, Dao T, et al: Prognostic factors affecting adrenalectomy in patients with metastatic cancer of the breast. Cancer 27: 1106, 1971.PubMedCrossRefGoogle Scholar
  79. 78.
    Scott WH Jr, Foster JH, Rhamy RK, et al: Surgical management of adrenocortical tumors with Cushing’s syndrome. Ann Surg 173: 892, 1971.PubMedCrossRefGoogle Scholar
  80. 79.
    Scott HW, Jr, Liddle GW, Harris AP, et al.: Diagnosis and treatment of Cushing’s syndrome. Ann Surg 155: 696, 1962.CrossRefGoogle Scholar
  81. 80.
    Silen W, Biglieri EG, Slaton, P. et al: Management of primary aldosteronism: evaluation of potassium and sodium balance, technic of adrenalectomy, and operative results in 24 cases. Ann Surg 164: 600, 1966.PubMedCrossRefGoogle Scholar
  82. 81.
    Silverstein MJ, Byron RL, Jr, Yomemoto RH, et al: Bilateral adrenalectomy for advanced breast cancer: A 21 year experience. Surgery 77: 825, 1975.PubMedGoogle Scholar
  83. 82.
    Sipple JH: The association of pheochromocytoma with carcinoma of the thyroid gland Am J Med 31: 163, 1961.CrossRefGoogle Scholar
  84. 83.
    Sjoerdsma A, Engelman K, Spector S, et al: Inhibition of catecholamine synthesis in man with alpha-methyl-tyrosine, an inhibitor of tyrosine hydroxylase. Lancet 2: 1092, 1965.PubMedCrossRefGoogle Scholar
  85. 84.
    Sjoerdsma A, Engelman K, Waldmann TA, et al: Pheochromocytoma: current aspects of diagnosis and therapy. Ann Intern Med 65: 1302, 1966.Google Scholar
  86. 85.
    Smithline F, Sherman L, Kolodny HD: Prolactin and breast carcinoma. N Engl JMed 292: 784, 1975.CrossRefGoogle Scholar
  87. 86.
    Sprague RG, Priestley JT, Weeks RE, et al: Treatment of Cushing’s syndrome by adrenalectomy, in Modern Trends in Endocrinology, Second series ( H Gardiner-Hill, editor). Harper Row, New York, 1961, p. 84.Google Scholar
  88. 87.
    Stackpole RH, Melicow MM, Uson AC: Pheochromocytoma in childhood. J Pediatr 63: 315, 1963.CrossRefGoogle Scholar
  89. 88.
    St Cyr MJ, Sancho JM, Melby JC: Quantitation of plasma aldosterone by radio-immunoassay. Clin Chem 18: 1395, 1972.Google Scholar
  90. 89.
    Steiner AL, Goodman AD, Powers SR: Study of a kindred with pheochromocytoma, medullary thryoid carcinoma, hyperparathyroidism, and Cushing’s disease: Multiple endocrine neoplasia, type 2. Medicine 47: 371, 1968.PubMedCrossRefGoogle Scholar
  91. 90.
    Stoll BA: Hormonal Management of Breast Cancer. JB Lippincott, Philadelphia, 1969.Google Scholar
  92. 91.
    Sturman MF, Moses DC, Beierwaltes WH, et al: Radiocholesterol adrenal images for the localization of pheochromocytoma. Surg Gynecol Obstet 138: 177, 1974.PubMedGoogle Scholar
  93. 92.
    Thorn GW, Lauler DP: Clinical therapeutics of adrenal disorders. Am J Med 53: 673, 1972.PubMedCrossRefGoogle Scholar
  94. 93.
    Tucker RM, Hunt JC: Recent advances in the medical and surgical treatment of hypertension. Med Clin North Am 52: 1227, 1968.PubMedGoogle Scholar
  95. 94.
    Tyler FH, West CD: Laboratory evaluation of disorders of the adrenal cortex. Am J Med 53: 664, 1972.PubMedCrossRefGoogle Scholar
  96. 95.
    Van Way CW III, Scott HW, Jr, Page DL, et al: Pheochromocytoma (Current Problems in Surgery). Yearbook Publishers, Chicago, 1974.Google Scholar
  97. 96.
    Weichert RF: The neural ectodermal origin of the peptide-secreting endocrine glands: a unifying concept for the etiology of multiple endocrine adenomatosis and the inappropriate secretion of peptide hormones by nonendocrine tumors. Am J Med 49: 232, 1970.PubMedCrossRefGoogle Scholar
  98. 97.
    Weinberger MA: Pheochromocytoma. Arch Intern Med 112: 667, 1963.Google Scholar
  99. 98.
    Williams ED: A review of 17 cases of carcinoma of the thyroid and pheochromocytoma. J Clin Pathol 18: 288, 1965.PubMedCrossRefGoogle Scholar
  100. 99.
    Wilson RE, Piro AJ, Aliapoulios MA, et al: Evaluation of adrenalectomy and hypophysectomy in the treatment of metastatic cancer of the breast. Cancer 24: 1322, 1969.PubMedCrossRefGoogle Scholar
  101. 100.
    Young HH: A technique for simultaneous exposure and operation on the adrenals. Surg Gynecol Obstet 54: 179, 1936.Google Scholar

Copyright information

© Springer Science+Business Media New York 1975

Authors and Affiliations

  • Anthony J. Edis
    • 1
  • Luis A. Ayala
    • 2
  • Richard H. Egdahl
    • 3
  1. 1.Department of SurgeryMayo ClinicRochesterUSA
  2. 2.Centro Médico de CaracasPlaza El EstanqueSan Bernardino, Caracas 101Venezuela
  3. 3.Boston University Medical CenterBostonUSA

Personalised recommendations